Idenix Pharmaceuticals, Inc. (IDIX) Reports First Quarter 2014 Financial Results And HCV Pipeline Review
5/1/2014 4:42:32 PM
CAMBRIDGE, Mass., May 1, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today reported unaudited financial results for the first quarter ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by